Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Cleveland Clinic at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Cleveland Clinic brings 54 presentations to ASH 2026 in New Orleans, and exhibits at Booth 131. Its program spans blood cancers, CAR T-cell therapy, and clotting and red cell disorders, along with medical education. It covers topics such as cytomegalovirus after BCMA CAR T therapy and a national survey of hematology-oncology fellows.

OrganizationASH 2026 Attendance
Cleveland Clinic
Cleveland, OH
Hospitals & cancer centres
Nonprofit academic medical center in Cleveland, Ohio; its Taussig Cancer Institute offers blood cancer care, stem cell transplant and CAR T-cell therapy.
Booth
Exhibiting at Booth 131 · Cleveland Clinic Cancer Institute
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00am–10:00am
Breaking News: Launching Bispecific Antibodies for Multiple Myeloma in Community Practice
Bringing bispecific antibodies for multiple myeloma into community clinics, with patient selection, sequencing, toxicity management, and outpatient setup.
Myeloma · New drugs
Session
Fri Dec 11
5:15pm–5:57pm
New Discoveries
New disease genes and syndromes for inherited blood cancer and marrow failure, plus lessons from variant curation and guideline groups.
Leukemias · Blood biology
Session
Sun Dec 13
11:15am–12:15pm
ASH Poster Walk on Innovations in Hemostasis and Thrombosis Clinical Research Design Hosted by Blood Vessels, Thrombosis & Hemostasis
Clinical trial design and statistical methods for bleeding and clotting research, shown through hemostasis and thrombosis studies.
Clotting
Talk
Sun Dec 13
4:30pm–5:45pm
Role of Inflammasome Inhibitors in the Intersection of CH and Thrombosis
Drugs that block the inflammasome and interleukin-1 signaling as a way to prevent clots and heart disease in people with clonal hematopoiesis.
Clotting · Blood biology
Session
Mon Dec 14
2:45pm–4:00pm
Balancing Bleeding and Clotting: Extended VTE Treatment for Whom and at What Dose?
Who should stay on blood thinners after a first clot, and at what dose, weighing recurrence against bleeding over years.
Clotting

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Cleveland Clinic

Tell us what you sell and we’ll find the people at Cleveland Clinic most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction